- Dr. Kirsten Smith is a kratom scientist with personal experience in drug abuse and withdrawal, as well as academic interest in the subject.
- Her research draws attention to the real reasons people use kratom, specifically for supporting various health issues.
- Smith’s path-breaking studies shine a light on the data gaps in kratom research and the resulting bans and prohibitions on kratom use by the government.
Meet Dr. Kirsten Smith. She’s a behavioral health scientist at Johns Hopkins, and right now, she’s tackling one of the most polarizing questions in public health: Is kratom dangerous or beneficial?
The herbal product used by millions of Americans is caught in a tug-of-war. Advocates call it a natural remedy, while regulators claim it’s addictive and understudied. Dr. Smith and her team at Johns Hopkins’ Behavioral Pharmacology Research Unit are among the first to document kratom’s properties, risks, and potential user dependency.
But before we dive into Smith’s groundbreaking research on kratom, let’s learn a bit about her.
Personal Background
Dr. Kirsten Smith’s expertise on kratom and addiction isn’t just academic—it’s deeply personal. Long before she joined Johns Hopkins as a researcher, she battled addiction. By 23, it escalated to legal trouble and time in federal prison, where she detoxed without support.
That experience drives her work today. Kirsten says, “Because of my past, I might be more interested in and more sympathetic to why people would want to take something to feel better, especially if they’re not getting the care they need or want.” But the turning point was yet to come.
In 2015, while working at a Kentucky addiction clinic, a client confessed that he was using kratom to feel better. “He said it made him feel good but not high,” she remembers. But when the clinic found out the client was using kratom, they expelled him.
The loss shattered Smith. Frustrated by a judgmental and punishment-driven system, she left clinical work. “I didn’t want to spend my life putting Band-Aids on gunshot wounds. I wanted to take the gun apart and figure out how it works,” she says.
Research Career
Dr. Kirsten Smith’s path to becoming a leading kratom researcher was complex. After earning a master’s in clinical social work from the University of Kentucky and a Ph.D. from the University of Louisville, she spent four years at the National Institute on Drug Abuse (NIDA), studying how opioid medications affect people.
By 2024, she’d shifted focus to kratom’s real-world impact. Leading a major NIDA-funded study, she surveyed hundreds of users and uncovered a paradox. While many relied on kratom for their wellness, hard data on its safety and effectiveness remained scarce. In a review paper, Smith and colleagues tackled the murky process of diagnosing kratom use disorder (KUD), proposing a step-by-step guide for clinicians.
Today, at Johns Hopkins, she runs the Kratom Research Unit—a first-of-its-kind lab dedicated to studying kratom’s effects in humans. Using everything from brain scans to population surveys, her team is peeling back layers on the mystery that surrounds kratom.
Revolutionary Findings
“It’s understandable to think that if you can get high from it, it must be bad,” she says. “But do we want to have a moral panic freakout about it? Or do we want to approach it in a sensible manner?”
She obviously vouched for the latter. The following are some of the most significant revelations from Dr. Kirsten Smith’s years of kratom research:
- Kratom is different from opioids. Kratom comes from the leaves of a tropical tree in the coffee family, native to Southeast Asia. Its alkaloids (mitragynine and 7-hydroxymitragynine) interact with the brain differently than traditional opioids. The mechanisms overlap, but the risks and effects aren’t the same. So, there is no basis for clinicians to lump kratom and opioids together into a similar classification.
- Most kratom users aren’t chasing a high. Smith’s research reveals that most people usually turn to kratom due to gaps in healthcare. Users are united by desperation. They are trying to solve health problems that either cannot be fixed with prescription drugs or are dismissed by doctors. It raises the question: Why are so many people forced to experiment in the dark?
- Kratom users run the risk of dependencies and withdrawals. A part of Smith’s studies focuses on Kratom Use Disorder (KUD). Like other substance use disorders, it involves tolerance (needing more kratom to feel the same effect), withdrawal symptoms (if users stop), and intense cravings. But unlike other addictions, people with KUD often keep their jobs, relationships, and daily routines intact. It doesn’t disrupt their lives.
“What we see are people rebuilding their lives,” Smith says.